NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/20/2024
Back to search
Official data from USPTO
OPTIBUMIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
12/20/2024
Classification
Registered
Trademark type
Word
Nice classes
1, 5
Filing date
07/13/2018
Registration date
05/14/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2024
Last transaction
12/20/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
07/31/2015
First use in commerce
07/31/2015
Drawing code
4
Owner type
03
Owner location
JUNCTION CITY, KS, US
Examiner
YOUNG, THOMAS PAUL
Current location
Historical data usage
Holders and representatives
Holders
INVITRIA, INC.
Ventria Bioscience Inc.
Representatives
Crissa A. Seymour Cook HOVEY WILLIAMS LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Recombinant albumin in the nature of excipients for use in the manufacture of pharmaceutical preparationscellular therapiesgene therapies and vaccines; Recombinant albumin for use as a reagent for scientific and research usebiomedical research and development
Class 5
Recombinant albumin for biological therapeutic purposes; Recombinant albumin for use as a reagent for medical usein-vitro fertilizationtissue sealanttissue and cell cryopreservationblood detoxification
Publications
History of USPTO decisions and trademark events.
23 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/20/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/20/2024
E815
TEAS SECTION 8 & 15 RECEIVED
07/22/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/14/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/13/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/26/2019
PUBO
PUBLISHED FOR OPPOSITION
02/26/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/06/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/19/2019
ALIE
ASSIGNED TO LIE
01/19/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/02/2019
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
11/02/2018
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
11/02/2018
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
11/02/2018
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
11/02/2018
DOCK
ASSIGNED TO EXAMINER
11/01/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/17/2018
NWAP
NEW APPLICATION ENTERED
07/17/2018
Continuous trademark protection
Get notified about every new filing that threatens OPTIBUMIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.